eyonis® Liver
Liver Disease/Cancer
Key Facts
About Median Technologies
Median Technologies is a dual-platform oncology company that transforms medical images into actionable insights for drug development and patient care. Its core achievements include building a profitable Imaging Lab service business supporting over 220 clinical trials and securing FDA 510(k) clearance for its flagship eyonis® LCS device for lung cancer screening. The company's strategy is to leverage its unique clinical expertise and AI platform to become a leader in AI-powered oncology diagnostics while scaling its high-margin imaging services globally.
View full company profile